Clarithromycin resistance, but not CYP2C-19 polymorphism, has a major impact on treatment success in 7-day treatment regimen for cure of H. prlori infection: A multiple logistic regression analysis

Digestive Diseases and Sciences

Volumn 46, Issue 11, 2001, Pages 2445-2450

  Miwa, H ^a   Misawa, H ^a   Yamada, T ^a   Nagahara, A ^a   Ohtaka, K ^a   Sato, N ^a  

^a JUNTENDO UNIVERSITY   (Japan)

Author keywords

13C urea breath test; Eradication treatment; PPI AC regimen; Predictive factor; Susceptability

Indexed keywords

AMOXICILLIN; CLARITHROMYCIN; CYTOCHROME P450 2C19; OMEPRAZOLE;

ADULT; AGED; ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; ARTICLE; COHORT ANALYSIS; CONTROLLED STUDY; ERADICATION THERAPY; FEMALE; GENE MUTATION; GENETIC CODE; GENETIC POLYMORPHISM; GENOTYPE; GRAM NEGATIVE INFECTION; HUMAN; MAJOR CLINICAL STUDY; MALE; PEPTIC ULCER; PREDICTION; PRIORITY JOURNAL; REGRESSION ANALYSIS; TREATMENT OUTCOME;

AMOXICILLIN; ANTI-BACTERIAL AGENTS; ARYL HYDROCARBON HYDROXYLASES; CLARITHROMYCIN; CYTOCHROME P-450 ENZYME SYSTEM; DRUG RESISTANCE, BACTERIAL; DRUG THERAPY, COMBINATION; DYSPEPSIA; FEMALE; H(+)-K(+)-EXCHANGING ATPASE; HELICOBACTER INFECTIONS; HELICOBACTER PYLORI; HUMANS; LOGISTIC MODELS; MALE; MIDDLE AGED; MIXED FUNCTION OXYGENASES; OMEPRAZOLE; PENICILLINS; PEPTIC ULCER; POLYMORPHISM, GENETIC; PROSPECTIVE STUDIES; TIME FACTORS; TREATMENT OUTCOME;

EID: 0034767327     PISSN: 01632116     EISSN: None     Source Type: Journal    
DOI: 10.1023/A:1012371702918     Document Type: Article

References (33)

1. Relationship between eradication therapy and clarithromycin-resistant Helicobacter pylori in Japan
2. Effect of smoking and histological gastritis severity on the rate of H. pylori eradication with omeprazole, amoxicillin, and clarithromycin
3. Are one-week anti-H. pylori treatments more effective an patients with peptic ulcer disease (PUD) than in those with non-ulcer dyspepsia (NUD)?
4. High Helicobacter pylori numbers are associated with low eradication rate after triple therapy
5. Gastric urease activity is inversely associated with the success of treatment for Helicobacter pylori: Effect of sofalcone
6. Bacterial density of Helicobacter pylori predicts the success of triple therapy in bleeding duodenal ulcer
7. Patient factors that predict failure of omeprazole, clarithromycin, and tinidazole to eradicate Helicobacter pylori
8. Predictors of failure of Helicobacter pylori eradication and predictors of ulcer recurrence: A randomized controlled trial
9. Clarithromycin resistance in Helicobacter pylori: Implication for therapy
10. The MACH study: Role of omeprazole in eradication of Helicobacter pylori with 1-week triple therapies
11. The prevalence of the drug resistance in Helicobacter pylori and the effects of the resistance on the eradication therapy in Japan
12. Failed treatment of Helicobacter pylori infection associated with resistance to clarithromycin
13. Clarithromycin as monotherapy for eradication of Helicobacter pylori: A randomized, double-blind trial
14. Eradication of Helicobacter pylori with clarithromycin and omeprazole
15. 13C-urea breath test and gastric mucosal colonization by Helicobacter pylori in children: Quantitative relation and usefulness for diagnosis of infection
16. Effect of genetic differences in omeprazole metabolism on cure rates for Helicobacter pylori infection and peptic ulcer
17. New developments in Helicobacter pylori eradication therapy
18. What other regimens are under investigation to treat Helicobacter pylori infection?
19. Genotyping of S-mephenytoin 4′-hydroxylation in an extended Japanese population
20. The major genetic defect responsible for the polymorphism of S-mephenytoin metabolism in humans
21. Identification of a new genetic defect responsible for the polymorphism of (S)-mephenytoin metabolism in Japanese
22. 13C urea breath test for detection of Helicobacter pylori infection withy fasting subjects
23. 13C urea breath test for detection of H. pylori infection in fasting patients
24. Efficacy of 1 week PPI/AC therapy for H. pylori infection in the Japanese population
25. Effectiveness of OAC therapy for H. pylori infection in Japanese population
26. Impact of rabeprazole, a new proton pump inhibitor, in PPI/AC therapy for Helicobacter pylori infection - Comparison with omeprazole and lansoprazole
27. Factors influencing the eradication of Helicobacter pylori with triple therapy
28. Pharmacokinetics of omeprazole (a substrate of CYP2C19) and comparison with two mutant alleles, C gamma P2C19m1 in exon 5 and C gamma P2C19m2 in exon 4, in Japanese subjects
29. The role of antisecretory drugs in the treatment of Helicobacter infection
30. Omeprazole may exert both a bacteriostatic and a bacteriocidal effect on the growth of Helicobacter pylori (NCTC 11637) in vitro by inhibiting bacterial urease activity
31. Comparison of the efficacy of 400 mg and 800 mg of clarithromycin used with lansoprazole and amoxicillin in eradication regimens for H. pylori infection in Japanese population
32. Interethnic differences in genetic polymorphism of mephenytoin hydroxylation among four oriental populations
33. Genetic polymorphism of mephenyton p(4)-hydroxlation: Difference between orientals and caucasians